TRIDENT LIFELINE
Back to Balance Sheet
|
TRIDENT LIFELINE Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Sundry Debtors | ₹28 Cr | ₹13 Cr | ₹12 Cr | ₹4.97 Cr |
What is the latest Sundry Debtors ratio of TRIDENT LIFELINE ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹28 Cr |
| Mar2024 | ₹13 Cr |
| Mar2023 | ₹12 Cr |
| Mar2022 | ₹4.97 Cr |
How is Sundry Debtors of TRIDENT LIFELINE Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹28 Cr | 105.93 | |
| Mar2024 | ₹13 Cr | 11.19 | |
| Mar2023 | ₹12 Cr | 143.46 | |
| Mar2022 | ₹4.97 Cr | - | |
Compare Sundry Debtors of peers of TRIDENT LIFELINE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TRIDENT LIFELINE | ₹347.5 Cr | -5.4% | -3.2% | 2.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹381,326.0 Cr | -0.2% | -6.3% | -8.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,299.0 Cr | 3.3% | -3.4% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹132,821.0 Cr | -0.7% | 3.8% | 26.3% | Stock Analytics | |
| CIPLA | ₹106,655.0 Cr | -3% | -11.8% | -8.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,861.0 Cr | 6% | -3.5% | -4.3% | Stock Analytics | |
TRIDENT LIFELINE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TRIDENT LIFELINE | -5.4% |
-3.2% |
2.3% |
| SENSEX | 0.8% |
-2.9% |
8.1% |
You may also like the below Video Courses